makers of semaglutide Ozempic maker Novo Nordisk wants the FDA to crack down on knockoff weight loss drugs semaglutide lawsuit compounding Filed Against

Glucagon Receptor Activation The glucagon receptor is the game changer

Continuing studies are investigating how this new mechanism may assist those who have not responded to other medications

GLP-1 medications are not approved and generally not effective for type 1 diabetes because the autoimmune destruction of beta cells means there are no functioning insulin-producing cells for GLP-1 to stimulate

Phospholipids in cellular membranes depend on inositol to carry out a number of biological processes

The human bias toward immediate comfort over distant benefit often prevails

Mice that successfully found the platform were permitted to remain on it for 15 seconds before being returned to their home cage